
Vitiligo is a chronic autoimmune skin condition affecting up to 2 percent of the global population where the immune system attacks melanocytes, causing depigmentation patches.
The condition primarily manifests as non-segmental or segmental vitiligo, with genetic susceptibility and environmental triggers playing significant roles in its onset.
Diagnostic evaluations include Wood's lamp examinations, while management strategies involve topical treatments, narrowband UVB phototherapy, and re-pigmentation procedures.